Both of us have dedicated our careers to advancing food safety and protecting the public. We’ve both done so at the height of federal service, in academic settings, as well as within the private sector. That’s why we believe we’re well qualified to provide a perspective on this issue.
Today, the U.S. Food and Drug Administration issued warning letters to three infant formula manufacturers as part of the agency’s ongoing commitment to enhance regulatory oversight to help ensure that the industry is producing infant formula under the safest conditions possible.
EPA’s James “Jim” Jones was named Wednesday as the first FDA Deputy Commissioner for Human Foods.
In an expanded position, he will fill the voids left at the FDA by the February departure of Frank Yiannas, who was the Deputy Commission for the then Food Policy Office, and the May retirement of Susan Mayne, who headed the Office of Food Safety and Applied Nutrition.
Today, the U.S. Food and Drug Administration is announcing the selection of James “Jim” Jones to serve as the first Deputy Commissioner for Human Foods. The new executive position will lead the charge in setting and advancing priorities for a proposed unified Human Foods Program (HFP).
The Food and Drug Administration on Wednesday announced the selection of its first deputy commissioner for human foods — part of an effort to reorganize the agency’s oversight of food safety after contaminated baby formula caused major shortages last year.
The U.S. Food and Drug Administration (FDA) has opened a docket to seek public comment on a report outlining a potential framework for establishing a public-private partnership (PPP) to collect and analyze antimicrobial use (AMU) data from food-producing animals.
Officials with the FDA are seeking feedback from the public on a report1 outlining a potential framework for establishing a public-private partnership (PPP) to collect and analyze antimicrobial use (AMU) data from food-producing animals. The report was prepared for the FDA by the Reagan-Udall Foundation and summarizes the work completed over a multi-year cooperative agreement funded by the FDA.2
The Reagan-Udall Foundation for the U.S. Food and Drug Administration (FDA) has published a new report, titled, Establishing a Draft Framework for a Public-Private Partnership to Support the Tracking of Antimicrobial Use in Food-Producing Animals.
